dopamine News
Most Popular dopamine Story
Glutamate a big target for drug developers
The New York Times' Alex Berenson looks at the wave of new research programs focused on the neurotransmitter Read more...
Latest Headlines
- February 25, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


